- In-utero electroporation was highlighted as a promising technique for developmental biology and potential gene-editing applications.  
- A new zkSNARK construction, “Doubly-efficient zkSNARKs without trusted setup,” was shared (eprint.iacr.org/2017/1132), pointing toward privacy-preserving verification tools for future bio-data marketplaces.  
- GenomicPrediction.com and related coverage in MIT Technology Review framed the emerging practice of embryo selection for health, height, and other polygenic traits as “eugenics 2.0,” sparking discussion on near-term feasibility and ethics.  
- BuzzFeed’s report on startups paying consumers for genomic data was circulated, underscoring the rise of direct-to-consumer DNA monetization platforms.  
- Community members debated the practicality of DIY gene therapy versus germline editing, concluding that IVF plus CRISPR currently offers higher efficacy and simpler delivery than systemic adult gene therapy.  
- A 250-page open-access IVF laboratory manual (libgen MD5 2E4365ABA3C43CECD44CADF14ABA8252 and mirrored at diyhpl.us) was identified as a concise starting resource for setting up low-cost IVF labs.  
- Ascendance Biomedical’s attempt to label an experimental HIV gene therapy as “research product” rather than medicine was criticized as a weak regulatory dodge; the broader ICO/blockchain-funding trend in biohacking was labeled “hyper scammy.”  
- Participants noted that surplus biotech equipment from failed fertility clinics often sells for pennies on the dollar, suggesting a viable route for bootstrapping open-source reproductive-technology labs.  
- Questions were raised about the availability of the incomplete textbooks “Diamond Surfaces and Diamond Mechanosynthesis” and “Fundamentals of Nanomechanical Engineering,” with links on diyhpl.us flagged as possibly out-of-date.